OMERS ADMINISTRATION Corp Boosts Stock Position in Agilent Technologies, Inc. $A

OMERS ADMINISTRATION Corp boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 31.4% in the first quarter, Holdings Channel reports. The institutional investor owned 16,074 shares of the medical research company’s stock after purchasing an additional 3,840 shares during the period. OMERS ADMINISTRATION Corp’s holdings in Agilent Technologies were worth $1,832,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in A. Waverly Advisors LLC increased its holdings in shares of Agilent Technologies by 24.9% during the first quarter. Waverly Advisors LLC now owns 4,693 shares of the medical research company’s stock valued at $535,000 after acquiring an additional 936 shares in the last quarter. Entropy Technologies LP boosted its stake in Agilent Technologies by 25.6% in the 1st quarter. Entropy Technologies LP now owns 88,083 shares of the medical research company’s stock worth $10,040,000 after purchasing an additional 17,978 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its position in Agilent Technologies by 440.5% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 60,573 shares of the medical research company’s stock valued at $6,904,000 after purchasing an additional 49,366 shares during the last quarter. Renaissance Technologies LLC purchased a new stake in Agilent Technologies during the 1st quarter valued at about $34,228,000. Finally, Gabelli Funds LLC increased its stake in Agilent Technologies by 34.7% during the 1st quarter. Gabelli Funds LLC now owns 7,854 shares of the medical research company’s stock valued at $895,000 after purchasing an additional 2,024 shares in the last quarter.

Agilent Technologies Trading Down 0.2%

Shares of A stock opened at $140.31 on Thursday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The stock has a market capitalization of $39.63 billion, a P/E ratio of 28.17, a P/E/G ratio of 2.49 and a beta of 1.25. The firm’s 50 day moving average is $131.41 and its 200 day moving average is $125.27.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts expect that Agilent Technologies, Inc. will post 6.01 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were given a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on A shares. HSBC dropped their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Barclays raised their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Robert W. Baird upped their price objective on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Wells Fargo & Company cut their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. Finally, Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their price target for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $159.35.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.